ARRONAX (Accelerator for Research in Radiochemistry and Oncology in Nantes-Atlantique) is a particle accelerator. It produces innovative radioisotopes (radioactive atoms) for research in nuclear medicine to explore the effects of radiation on non-living and living matter.
The CEISAM chemistry laboratory (UMR 6230 CNRS – University of Nantes) brings together fundamental methodological know-how in organic synthesis, analytical bio-organic chemistry and molecular modeling.
The nuclear medicine department of the University hospital of Nantes carries out clinical trials for diagnosis and therapy in the fields of oncology, cardiology and neurology.
The Nantes-Angers Oncology and Immunology Research Center (CRCI2NA, Inserm UMR 1307 / CNRS UMR 6075) has 400 staff divided into 17 research teams. Its work more particularly aims to develop diagnostic and therapeutic tools to fight cancer, focusing on the vectorization of radionuclide targeting cancer cells, and on their biological effects.
The Institut de Cancérologie de l’Ouest is staffed by 1300 professionals, including 200 doctors, researchers, pharmacists and biologists. Some of these practitioners participate in research work in cancer-related disciplines, including nuclear medicine.
The Laboratoire des Sciences du Numérique of Nantes (UMR 6004) brings together 450 people working in digital sciences.
The CRIP of Oniris (formerly the Ecole Nationale Vétérinaire (National Veterinary School) of Nantes) has equipment dedicated to oncology, including an imaging platform and a radiotherapy and radionuclide therapy platform for animals.
In the space of 50 years, the University of Nantes has taken training, innovation and research to the highest level. It is now in the limelight, both in France and abroad, due to the intensity of its development.
Subatech (UMR 6457 -IMT Atlantique, IN2P3/CNRS, University of Nantes) conducts research in the area of Nuclear and Health. The work of its researchers in this field concerns the study of radionuclide properties and the physical chemistry under radiation for medical applications, the interaction of radiation and particles with the matter, and their use for the production of innovative radionuclides, dosimetric studies for radiobiology and new medical imagery techniques.